chr7-151632145-G-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_016203.4(PRKAG2):c.685-7C>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000374 in 1,391,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016203.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKAG2 | NM_016203.4 | c.685-7C>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000287878.9 | NP_057287.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRKAG2 | ENST00000287878.9 | c.685-7C>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_016203.4 | ENSP00000287878 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00000668 AC: 1AN: 149756Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000411 AC: 51AN: 1242180Hom.: 0 Cov.: 30 AF XY: 0.0000471 AC XY: 29AN XY: 616254
GnomAD4 genome AF: 0.00000668 AC: 1AN: 149756Hom.: 0 Cov.: 32 AF XY: 0.0000137 AC XY: 1AN XY: 73030
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 29, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 19, 2012 | Variant classified as Uncertain Significance - Favor Benign. The 685-7C>A varian t (PRKAG2) has not been reported in the literature, but has been detected in 1 i ndividual with HCM tested by our laboratory (this individual's daughter), who ca rried a second pathogenic variant in the TNNI3 gene. The 685-7C>A variant did no t segregate with disease in 1 affected relative, who carried the pathogenic TNNI 3 variant. The 685-7C>A variant is located in the 3' splice region but computati onal analyses do not predict altered splicing, though the accuracy of these tool s is unknown. Although this variant is likely to be benign when seen in isolatio n, we cannot rule out a modifying role. Additional information is needed to full y assess its clinical significance. - |
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | May 13, 2019 | - - |
Lethal congenital glycogen storage disease of heart Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 21, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at